Asthma + Lung UK

Asthma + Lung UK is the lung health charity fighting for everyone’s right to breathe. 

Why we’re fighting for breath

In the UK, respiratory care simply isn’t good enough.

Even before Covid-19, NHS hospital admissions for lung conditions were rising three times faster than average admissions.

Lung disease is now the third most common cause of death, costing the NHS more than £11 billion every year. So this issue needs to be at the top of the health agenda.

People living with lung conditions are often overlooked and being left behind. Their condition isn’t accurately diagnosed at an early stage – and even when they are diagnosed, they’re not given the care they need.

We fund cutting-edge research, and provide advice and support for the 12 million people who will get a lung condition during their lifetime. We also campaign for clean air and better NHS diagnosis and treatment.

Because breath is life – and it’s worth fighting for.

Blood Cancer Alliance

There are around 240,000 people living with blood cancer in the UK. Together, blood cancers are the fifth most common type of adult cancer, the most common cancer amongst children and the third most fatal cancer. Those living with blood cancer face unique challenges whilst undergoing diagnosis, treatment and on-going care.

The Blood Cancer Alliance is a group of fifteen UK charities. We are working to tackle the issues blood cancer patients face and improve the experience and outcomes of all those living with blood cancer.

We believe that equal priority in UK policymaking must be given to cancers, like blood cancer, that are more difficult to diagnose and rarely have surgical options for treatment. It is our collective ambition to see progress in the following areas:

Reducing delays to diagnosis: The number of blood cancer patients who had to see their GP five or more times before being referred to a specialist is more than double that of patients with other cancers. Around 30% of blood cancer patients are diagnosed in an emergency setting, when their cancer is likely to have progressed. Blood cancer patients deserve specific strategies to address this issue.

Improving access to innovative treatment: With few surgical treatment options available for blood cancer, innovation in treatment is critical to reducing mortality. However, there are significant challenges within the current UK model for adopting new treatments into the NHS.

Addressing inequality in care and experience: Blood cancer patients should have access to fair, equitable treatment, and the NHS must ensure national policies and health service design takes account of their specific and complex needs. However, from awareness, to diagnosis, to information, care and support, blood cancer patients are less likely to see their needs fully met than patients with the four most commons cancers.

British Heart Foundation

Heart attacks that strike without warning, strokes that shatter futures, newborn babies born with broken hearts. These are just some of the cruelties of cardiovascular disease. And the brutal reality is, there is so much more for science to discover before we can beat the world's biggest killers.

That's why British Heart Foundation exists. Funding research is how we beat cardiovascular disease. And we all have a role to play. The tools we have at our disposal today—from heart transplants and pacemakers to stents and portable defibrillators—are all down to research. Research is vital, and BHF currently fund the majority (52%) of all non-commercially funded research into heart and circulatory diseases, with our aim to find breakthroughs and to improve outcomes.

Our research has helped halve the number of people dying annually from these conditions since the 1960s—back then, more than seven out of ten heart attacks in the UK were fatal. Today, more than seven out of ten people survive. But there is still more work to be done, and we are always striving to find more breakthroughs so that people and families across the UK will have better chances and healthier lives.

Crohn's & Colitis

There are no two ways about it: a diagnosis of Crohn’s or Colitis is life changing. Here at Crohn’s & Colitis UK, we all know it, as does everyone affected by these devastating conditions. 

The problem is, not everyone else knows it. 

These chronic conditions are painful, debilitating and widely misunderstood. There is no known cure. Our mission starts now, to bring about Better Diagnosis, Better Care and Better Lives for the 500,000+ people living with the conditions in the UK. 

We are leading the fight against Crohn’s and Colitis. With your help, we’re going to change people’s lives for the better. The condition is life-changing, but so are our supporters. 

We are Crohn’s & Colitis UK. 

A national charity supporting everyone affected by Crohn’s Disease, Ulcerative Colitis and other forms of Inflammatory Bowel Disease (IBD). 

We exist to achieve a better quality of life for those affected, while fighting for earlier diagnosis, driving increased research funding and, ultimately, finding a cure.

In the UK, over half a million people are living with Crohn’s and Colitis. So that’s half a million reasons to join forces and help us demand better. We build strategic, impactful and mutually beneficial corporate partnerships to better support communities and people in need. 

Our partners are a crucial part of what comes next. We’ll work together not only to empower those living with the diseases, but also to have a significant impact on your business and employees too. 

Help us to lead the fight and be part of changing half a million lives for the better.

Kidney Research UK

For more than 60 years the research we fund has been making an impact.

But kidney disease is increasing. It is estimated that estimates there are 7.2 million people in the UK are currently living with chronic kidney disease, more than 10% of the entire population.  Factors contributing to kidney disease are also growing, such as diabetes, cardiovascular disease and obesity, and people with kidney disease are also at increased risk of heart attack or stroke.

At Kidney Research UK we work with clinicians and scientists across the UK, funding and facilitating research into all areas of kidney disease. We collaborate with partners across the public, private and third sectors to prevent kidney disease and drive innovation to transform treatments.
Over the last ten years we have invested more than £58 million into research. We lobby governments and decision makers to change policy and practice to ensure that more than 3 million people living with kidney disease in the UK have access to the most effective care and treatment, and to make kidney disease a priority.

Most importantly, we also work closely with patients, ensuring their voice is heard and is at the centre of everything we do, from deciding which research to invest in to how we plan our priorities and our work across the charity. Those patient contributions are vital, always helping us and our partners to understand what life is like with kidney disease, always ensuring we see the patient behind the treatment and always reminding us that behind every statistic and every number is a person – the patients and the carers who inspire our mission and push us forward to make a difference and change the future of kidney disease. 

Oracle Head and Neck Cancer UK

Oracle Head and Neck Cancer UK is the leading Head and Neck cancers charity in the UK, and our vision is to ensure everyone has the best chance of surviving Head and Neck cancers. With your support we will do this by enabling greater awareness, knowledge and understanding of Head and Neck cancers. 

Our mission is to improve Head and Neck Cancer patient quality of life and outcomes. 

The number of new head and neck cancer cases on average each year in the UK is projected to rise from around 14,000 cases in 2023-2025 to around 16,300 cases in 2038-2040. By 2027 Oracle will have made visible impact on the RACE against the crisis in Head and Neck cancers:

• Research projects that we have funded will provide more understanding about these cancers, how best to treat them and where the greatest unmet needs are;
• Awareness campaigns around Head and Neck cancers, their symptoms and prevention measures;
• Collaboration programmes that promotes knowledge sharing and improvebest practice;
• Experience and care pathway support becoming more accessible and visible for patients of all backgrounds.

Sickle Cell Society

The Sickle Cell Society is the only national charity in the UK that supports and represents people affected by a sickle cell disorder to improve their overall quality of life.

First set up as a registered charity in 1979, the Sickle Cell Society has been working alongside health care professionals, parents, and people living with sickle cell to raise awareness of the disorder. The Society’s aim is to support those living with sickle cell, empowering them to achieve their full potential. 

The Sickle Cell Society believes that individuals with sickle cell have the right to quality care. This can only be achieved if funding is made available to educate health carers and other professionals about the condition. The Society aims to provide this.
The Society does not discriminate between the types of sickle cell disorders or the ethnic groups concerned. Both sexes are equally affected, and should have equal access to support and services within a confidential and sensitive environment. We respect the views of every patient. 

We have a network of committed volunteers, who play an important part in running the charity, providing administrative backup, and helping with fund-raising activities. 

Donations from the public and fundraising activities are also part of our life support. Without them, we would be unable to finance the essential research and educational projects and we would be unable to offer children a much-needed summer retreat. The Society benefits from the support of a wide range of individuals and organisations nationally, who together play a vital role in its success.